Goldman Sachs Group Inc Jaguar Health, Inc. Transaction History

Goldman Sachs Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 May 14, 2024	BUY	$0.27 - $0.71 $3,158 - $8,304	11,697 New	11,697 $3,000
Q2 2022 Aug 15, 2022	SELL	$0.27 - $0.71 $11,629 - $30,581	-43,073 Reduced 78.64%	11,697 $3,000
Q1 2022 May 16, 2022	BUY	$0.38 - $1.07 $12,596 - $35,468	33,148 Added 153.31%	54,770 $39,000
Q4 2021 Feb 14, 2022	BUY	$1.03 - $2.48 $22,270 - $53,622	21,622 New	21,622 $22,000

Ticker JAGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 119,861,000
Market Cap $125M
Description
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfecti...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.